乳腺病理学更新与争议
Updates and controversies in breast pathology.
PubMed 文献 · Hum Pathol · 2025-06-27
本文为《Human Pathology》乳腺病理专刊的引言,旨在更新乳腺病变领域的最新进展并讨论当前争议,重点关注形态学、免疫表型与分子改变的整合,这些对患者管理和预后具有重要意义,期望为病理实践提供循证的问题解决参考。
要点
- 乳腺病理强调形态学、免疫表型与分子改变的整合。
- 分子时代乳腺病变存在多个争议领域需深入讨论。
- 专刊旨在为病理实践提供循证参考。
核心结论
- 乳腺病理需整合形态学、免疫表型与分子改变以支持患者管理和预后判断。
主要发现
- 专刊关注乳腺病变中形态学、免疫表型与分子改变的整合。
临床怎么用
- 可作为乳腺病理循证实践的问题解决参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In the rapidly evolving molecular era, this special issue on breast pathology aims to provide a timely update on recent advancements and to foster thoughtful discussion on current controversies across the diverse landscape of breast lesions. Particular attention is given to the integration of morphology, immunophenotypic profiles, and molecular alterations, all of which have significant implications for patient management and prognosis. This issue aspires to serve as an evidence-based, and problem-solving reference to support and enhance best pathology practices.
来源:Hum Pathol,查看原文。版权归原作者所有。
引用
- Peng Y, Erickson LA. Updates and controversies in breast pathology. Hum Pathol. 2025. PMID: 40582650. doi:10.1016/j.humpath.2025.105864
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。